Compare TSSI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSSI | LAB |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 270.6M |
| IPO Year | 2005 | 2008 |
| Metric | TSSI | LAB |
|---|---|---|
| Price | $6.79 | $0.62 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | 782.0K | ★ 880.7K |
| Earning Date | 11-05-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.33 | 61.54 |
| EPS | 0.13 | ★ 0.29 |
| Revenue | ★ $245,719,000.00 | $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.51 | N/A |
| P/E Ratio | $53.92 | ★ $2.36 |
| Revenue Growth | ★ 65.86 | N/A |
| 52 Week Low | $6.63 | $0.59 |
| 52 Week High | $17.77 | $1.72 |
| Indicator | TSSI | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 38.25 | 38.17 |
| Support Level | N/A | $0.59 |
| Resistance Level | $10.52 | $0.79 |
| Average True Range (ATR) | 0.44 | 0.03 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 33.28 | 27.28 |
TSS Inc provides a comprehensive suite of services for the integration of complex Artificial Intelligence (AI) technologies, planning, design, deployment, maintenance, and refresh of end-user and enterprise systems, including the mission-critical facilities that are housed. It provides a single-source solution for enabling technologies in data centers, operations centers, network facilities, server rooms, security operations centers, communications facilities, and the infrastructure systems that are critical to their functions. Services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.